BIOFAC A/S: Financial statements 2022
CVR: 62550511
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
BIOFAC A/S (CVR 62550511) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 20,289,404 and a net result of DKK -5,952,699 compared with DKK -1,135,148 the year before. That is a decrease of 29.6% compared with the year before. Equity in the 2022 report amounted to DKK 12,644,146. The solvency ratio was 8.9%. The company had 76 employees in the financial year.
- Gross Profit
- DKK 20,289,404
- Profit/Loss
- DKK -5,952,699
- Equity
- DKK 12,644,146
- Total Assets
- DKK 142,566,347
- Employees
- 76
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 20.3 mio. | -6 mio. | 12.6 mio. | 76 |
| 2021 | - | 28.8 mio. | -1.1 mio. | 18.6 mio. | 71 |
| 2020 | - | 23.4 mio. | -4.2 mio. | 19.7 mio. | 68 |
| 2019 | - | 14.4 mio. | -7.9 mio. | 23.9 mio. | 71 |
| 2018 | - | 16.4 mio. | -7.3 mio. | 11.9 mio. | 68 |
Official annual report
Keep an eye on BIOFAC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BIOFAC A/S
BIOFAC A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1934. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Helle Rørvig, Niels Ulrik Heine and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 83 employees (2026). In 2025, the company reported a gross profit of DKK 73,647,426 and a net result of DKK -3,775,890 compared with DKK 332,520 the year before. Equity in the 2025 report amounted to DKK 10,810,382.